Verproside is primarily studied for its potential neuroprotective effects, making it a compound of interest in the development of treatments for neurodegenerative disorders such as Alzheimer's and Parkinson’s disease. It has demonstrated anti-inflammatory and antioxidant properties in neuronal cells, helping to reduce oxidative stress and inhibit the release of pro-inflammatory cytokines. These actions contribute to the protection of brain tissue from damage caused by neurotoxins or aging processes.

In addition, verproside shows promise in modulating neurotransmitter systems, particularly those involving dopamine and glutamate, which are critical in mood regulation and cognitive function. This suggests possible applications in managing depression, anxiety, and other central nervous system disorders.

It is also being explored for its anti-epileptic potential due to its ability to stabilize neuronal activity and reduce seizure frequency in preclinical models. While still in the research phase, verproside may serve as a lead compound for developing new classes of neuroactive drugs with fewer side effects compared to current therapies.